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Abstract. Early detection of pathological changes and progression in glaucoma and other neuroretinal diseases
remains a great challenge and is critical to reduce permanent structural and functional retina and optic nerve dam-
age. Raman spectroscopy is a sensitive technique that provides rapid biochemical characterization of tissues in a
nondestructive and noninvasive fashion. In this study, spectroscopic analysis was conducted on the retinal tissues of
seven beagles with acute elevation of intraocular pressure (AEIOP), six beagles with compressive optic neuropathy
(CON), and five healthy beagles. Spectroscopic markers were identified associated with the different neuropathic
conditions. Furthermore, the Raman spectra were subjected to multivariate discriminate analysis to classify inde-
pendent tissue samples into diseased/healthy categories. The multivariate discriminant model yielded an average
optimal classification accuracy of 72.6% for AEIOP and 63.4% for CON with 20 principal components being used
that accounted for 87% of the total variance in the data set. A strong correlation (R2 > 0.92) was observed between
pattern electroretinography characteristics of AEIOP dogs and Raman separation distance that measures the separa-
tion of spectra of diseased tissues from normal tissues; however, the underliningmechanism of this correlation remains
to be understood. Since AEIOPmimics the pathological symptoms of acute/early-stage glaucoma, it was demonstrated
that Raman spectroscopic screening has the potential to become a powerful tool for the detection and characterization
of early-stage disease. © 2013 Society of Photo-Optical Instrumentation Engineers (SPIE) [DOI: 10.1117/1.JBO.18.6.067008]
Keywords: glaucoma; early stage; acute elevation of intraocular pressure; compressive optic neuropathy; Raman spectroscopy; multi-
variate discriminate analysis; support vector machine; detection.
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1 Introduction
Glaucoma is a slowly progressive, chronic optic neuropathy that
is characterized by retinal ganglion cell (RGC) death with sub-
sequent loss of optic nerve axons and decrements in visual func-
tion. Glaucoma is diagnosed clinically by means of functional
and structural analysis of the retina and optic nerve. After an
initial diagnosis, these tests need to be repeated at regular inter-
vals to assess the progress of the disease and any treatment
effect. Unfortunately, a significant loss of retinal cells can
occur before any of the current tests show an abnormality.
Namely, between 25% and 35% of the RGCs could be lost
before any visual field defect is detectable.1 The detection of
progressive changes in glaucoma can also be demanding, requir-
ing multiple testing sessions over a prolonged period of time.
Hence, a critical gap exists to develop clinical tests that
could aid in the early diagnosis and monitoring of glaucoma.
Raman spectroscopy measures the inelastic scattering of
laser light by biomolecules in tissue samples and can be used
to predict the general biochemical composition of biological
samples.2 As such, it can be used to provide rapid characteriza-
tion of healthy versus diseased tissues in a nondestructive and
noninvasive fashion. In recent years, the technique has been
applied to characterize various biological samples, including
mineralized tissue such as bone and teeth,3,4 skin,5 brain,6 the
gastrointestinal tract,7 mouth,8,9 blood vessels,10 and breast.11
In ophthalmology, Raman spectroscopy has been used to deter-
mine carotenoid pigment levels in human retina,12,13 altered
vitreous molecules such as glycated collagen in diabetic
vitreoretinopathy,14 and the distribution of cholesterol in a rat
eye lens,15 as well as to detect glutamate in the vitreous of
porcine eyes in an ex vivo experiment.16
Raman spectroscopy provides rapid characterization of the
chemical composition and molecular structures in cells and tis-
sues. Diseases and other pathological anomalies lead to chemi-
cal and structural changes at the molecular level in tissues that
are reflected in their Raman spectra before the appearance of
clinical symptoms. These spectral changes can be used as sen-
sitive, phenotypic markers of disease17 and could potentially
lead to early disease diagnosis before clinical symptoms are
apparent. Once Raman spectra are acquired, mathematical clas-
sification techniques are utilized to differentiate the spectral
signatures of diseased and normal tissues. In our previous
study, Raman spectroscopic screening was utilized to detect
glaucomatous changes in retinal tissue with high specificity.18
The specimens analyzed in that study were obtained from canine
retinas with severe vision loss due to advanced hereditary angle-
closure glaucoma. The physiological and biochemical retinal
changes were quite significant in comparison to the healthy
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controls. It remains to be seen whether Raman spectroscopic
screening can be used to detect glaucomatous changes at earlier
stages of the disease in an animal model lacking any genetic
predisposition for ocular pathology.
In order to better understand glaucomatous changes that occur
at an early stage of glaucoma, it is essential to use animal models
that recapitulate the development of the disease that is character-
ized by a progressive loss of RGC function. Elevated intraocular
pressure (IOP) is considered a primary risk factor for the progres-
sion of glaucomatous neuropathy19,20 and remains the etiological
factor toward which all current therapeutic efforts are directed.
Acute elevation of intraocular pressure (AEIOP) induces defor-
mation of the lamina cribrosa and anterior scleral canal wall
and underlies the onset of optic nerve head surface hypercompli-
ance that is typically associated with an early stage of glaucoma.21
Compressive optic neuropathy (CON) occurs when lesions
appear along the optic nerve, which induces damage to the
optic nerve and a progressive loss of visual function and struc-
ture.22 Due to the similar size of the human and canine eye, func-
tional and structural data can be acquired using instrumentation
identical to that which is used in human patients.23,24 In this study,
retinal tissues from canine models of AEIOP and CONwere com-
pared to healthy control samples using Raman spectroscopy.
The primary purpose of this study was to explore the poten-
tial of using Raman spectroscopy for characterization of glau-
coma-like spectroscopic signatures at an early stage of retinal
damage to identify spectroscopic markers in the eyes and to
classify methods to effectively differentiate early-stage glau-
coma-like tissues and healthy tissues.
2 Materials and Methods
2.1 AEIOP in Beagles
Laboratory beagles were anesthetized with 2.5% halothane and a
mixture of nitrous oxide and oxygen (30∶70 ratio). Body temper-
aturewasmaintainedusingaheatingpad (T/Pump®Professional,
Gaymar Industries Inc., Buffalo, NY). The pupils were dilated
with topical 10% phenylephrine hydrochloride (Ak-dilate™,
Akorn Inc., Buffalo Grove, IL) and 1% tropicamide
(Tropicamide, Falcon Pharmaceuticals, Fort Worth, TX). Prior
to anterior chamber cannulation, the eye was surgically prepped
and a drop of 0.5% propracaine hydrochloride (Falcon
Pharmaceuticals) was instilled. The anterior chamber was then
cannulated with a 25-gauge needle connected to a reservoir con-
taining 0.9%NaCl. The IOP in experimental eyes was controlled
by adjusting the height of the reservoir to maintain a level of sys-
tolic blood pressure for 60 min. The systolic blood pressure was
evaluatedwith anultrasonicDoppler flowdetector (Model 811-L,
ParksMedical Electronics Inc., Las Vegas, NV) every 5 min. The
average elevation of IOPwas between 100 and 160mmHg. After
60 min, the bottle was lowered and the needle was subsequently
removed from the anterior chamber, and topical antibiotic oint-
ment (Vetropolycin, Pharmaderm Inc.,Melville,NY)was applied
onthecornea.Postoperativetreatment includedonedoseofhydro-
morphoneHCl (0.1 mg∕kg, Dilaudid, Abbott Laboratories, Lake
Forest, IL) subcutaneously and application of topical antibiotic
ointment to the operated eye twice daily for 2 days.25
2.2 Dog Model for CON
CON was induced in laboratory beagles by surgical implanta-
tion of custom-made silicone reservoir (Nagor LTD, Isle of Man,
United Kingdom) into the left orbit. Animals were premedicated
with intramuscular hydromorphone hydrochloride (0.1 mg∕kg;
Dilaudid®, Hospira, Inc., Lake Forest, IL) and acepromazine
maleate (0.01 mg∕kg, Vedco, Saint Joseph, MO). Anesthesia
was induced with intravenous administration of propofol (3
to 5 mg∕kg, Schering Plough Animal Health, Ethicon, NE)
and maintained with 1.5% to 2.5% halothane (Halocarbon
Laboratories, River Edge, NJ) in a mixture of 1∶1 oxygen
and nitrous oxide. Body temperature was maintained using a
heating pad and a heating blanket (Bair Hugger®, Arizant
Healthcare Inc., Eden Prairie, MN). Systolic, mean, and dia-
stolic blood pressures were recorded with oscillometric arterial
blood pressure monitor (Cardell Veterinary Monitor, Model
9401, Paragon Medical Supply, Coral Springs, FL) every
5 min and maintained in physiological levels with constant intra-
venous drip of lactated Ringer’s solution (10 mL∕kg for the first
hour, 5 mL∕kg after) during the orbital implant surgery and sub-
sequent recordings. Heart rate, hemoglobin saturation, respira-
tory rate, expired CO2, end-tidal CO2, and end-tidal
concentration of halothane were constantly monitored
(Datascope Multinex Plus anesthesia monitor, Absolute
Medical Equipment, New York, NY). After induction of anes-
thesia, the area around the left orbit and left side of the head was
clipped and prepared for aseptic surgical procedure. Intravenous
cefazolin (22 mg∕kg; Cefazolin, Sandoz Inc., Princeton, NJ)
was administered on a prophylactic basis, and the same dose
was repeated every 2 h throughout the procedure.
With the animals in sternal recumbence, a skin incision was
made above the left eye in the area of orbital ligament. The pal-
pebral nerve was identified and, where necessary, retracted with
sterile umbilical tape to avoid its damage during the procedure.
The orbital ligament was incised lengthwise to enable access to
the retrobulbar space. A Gelpi retractor was inserted into the
incision to enable good visualization of the surgical site, and
a custom-made inflatable silicone implant (Nagor) was intro-
duced into the orbit, directly behind the eye. The injection
port of the implant was passed through the incision in the orbital
ligament and under the skin of the forehead into the occipital
area, where it was fixed to the muscle fascia with absorbable
monofilament suture (PDS 3-0, Ethicon). Surgical incisions
were closed routinely. Postoperative analgesia and inflammation
control were maintained with hydromorphone hydrochloride
(0.1 mg∕kg body weight) every 6 to 8 h (as needed) for 3
days and carprofen (4.4 mg∕kg body weight) once daily for
7 days. The implant was inflated to a pressure that gave a com-
plete optic nerve perfusion deficit as measured using fluorescein
angiography. The device was then deflated until fluorescein was
observed in the retina.
2.3 Animals and Tissue Collection
All animal studies were conducted in accordance with the
Association for Research in Vision and Ophthalmology
Statement for Use of Animals in Ophthalmic and Vision
Research, and procedures were approved by the Iowa State
University Committee on Animal Care. Eyes were collected
from seven beagles with AEIOP and six beagles with CON
for 24 h were used for Raman spectroscopic investigation.
Additionally, eyes from five adult healthy beagles 6 months
of age were used as controls. All control animals underwent ocu-
lar examination (slit-lamp biomicroscopy, IOP evaluation, indi-
rect ophthalmoscopy, and gonioscopy) to rule out the possible
presence of ocular disease before inclusion in the study. Eyes
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were surgically removed from the beagles after euthanasia. They
were fixed in 10% buffered paraformaldehyde for 24 h, rinsed,
and paraffin embedded. Twenty-micron-thick retinal sections
were made and placed on gold–aluminum coated histology
slides for the purposes of Raman imaging. Raman spectra
were acquired from the fixed tissue sections using a Raman
microscope with 10× objective, with a laser spot size of
∼50 μm diameter.
2.4 Acquisition of Raman Spectra from Retinal
Tissues
In this study, Raman measurements were performed using a
DXR Dispersive Raman Microscope (Thermo Scientific, Inc.,
Madison, WI) with 780 nm, 14 mW excitation laser with a
charge-coupled device (CCD) camera and 50-μm pinhole in
ambient temperature. Raman spectra were collected with 99 s
exposure time from 600 to 2000 cm−1 at a resolution of 1 cm−1
(full-range grading).
2.5 Spectral Data Processing
The acquired Raman spectra were preprocessed to remove arti-
facts caused by background fluorescence and intensity fluctua-
tions.17,26 Using near-infrared excitation (780 nm) radically
reduces the observance of sample autofluorescence. To further
reduce the remaining fluorescence, a polynomial background
subtraction method was implemented.27 Another challenge in
spectral preprocessing is to capture important patterns in the
spectra while removing noise or other fine-scale structures.
The 10-point moving average method was used in this study
to smooth the spectra. Finally, all spectra were area normalized
for intensity consistency at the region between 600 and
2000 cm−1. All data processing was conducted using R, a
widely used open-source language and software tool for statis-
tical computing and graphics downloaded freely from the
Internet (www.>r-project.org).
2.6 Principal Component Analysis
In Raman spectra, each wave number represents a dimension or
variable. Commonly, data in one Raman spectrum contains
thousands of dimensions, which makes statistical analysis
much more challenging. For discriminant analysis, as the (num-
ber of) dimensions of the data becomes large, the limitation on
the capability of detecting distinguishable classes becomes
severe.28 Due to the fact that most statistical methods are
based on optimization criteria, it is advisable to reduce the
dimension(s) of the problem, which results in decreasing com-
putational costs and increasing probability of finding the best
model representing the data. For this purpose, often a principal
component regression is utilized:
Y ¼ L × ST þ E:
In the equation above, Y is the matrix of spectra, S is the
score matrix, L is the matrix of loadings, and E is the error
matrix. The data are compressed into principal component (PC)
scores.
All spectra were polynomial baseline corrected, smoothed
using moving average algorithms, and area normalized at the
region between 600 and 2000 cm−1 before principal component
regression was utilized. Ten to forty PCs (which account for at
least 90% of total variance in the data) were selected from thou-
sands of dimensional hyperspectral data as inputs for multivari-
ate discriminant classification model.
For each dog in AEIOP and CON groups, the calculated
PC spectra form a cluster. The average intracluster Euclidean
distances in the multidimensional PC space (one dimension rep-
resents one principal component for our data) are calculated
between each diseased dog and the control group (i.e., all spec-
tra from the control dogs). Our hypothesis is that more distin-
guishable spectroscopic signatures between diseased dogs and
the control group will translate into a higher separation distance
in the multidimensional PC space. Hence, the calculated average
distance may serve as a base for a disease score system that pre-
dicts the severity of the disease conditions. This hypothesis was
checked against AEIOP, CON, and late-stage close-angle glau-
coma, with mixed results. More work is needed to further refine
the disease score system.
2.7 Cross-Validation, Independent Validation, and
Discriminant Modeling
Cross-validation is a technique for assessing how the results of a
statistical analysis will generalize to an independent dataset.29
One round of cross-validation involves partitioning a sample
of data into complementary subsets, performing the analysis
on one subset (called the training set), and validating the analy-
sis on the other subset (called the validation set or testing set). To
reduce variability, multiple rounds of cross-validation are per-
formed using different partitions, and the validation results
are averaged over the rounds.
One inherent drawback of cross-validation comes from the
fact that the validation set and the training set are indeed spectra
measured from the same batch of samples (i.e., dogs). The high
prediction accuracy reported from cross-validated discriminant
models can be biased. In this study, to further confirm that
Raman spectroscopic data can yield enough information that
distinguishes diseased tissues from normal ones, even at an
early stage of the disease, we tested the discriminant model
by independent validation. In this approach, spectra from two
beagles in each group were randomly selected as validation
datasets that were excluded from the training pool used to create
the support vector machine (SVM) classification models. Ten
repetitions were conducted. Twenty PCs were used to develop
the discriminant model. The validation set only contains spectral
data that were acquired from an independent set of samples (i.e.,
dogs), with no overlap with the sample pool from which the
spectral data for the training of the discriminant model were
acquired.
In general, all spectra were baseline corrected, smoothed to
reduce the baseline variability, and normalized using R before
classification analysis. SVM based on R packages “e1071”30
with folded cross-validation was utilized as the discriminant
classification modeling technique.
2.8 Pattern Electroretinography Characterization of
the Disease Status of AEIOP Dogs
The pattern electroretinogram (pERG), which measures the reti-
nal response evoked by viewing a temporally alternating pattern,
is important in providing information about RGC function. With
appropriate paradigms, pERG is objectively correlated with
the overall RGC status.31 The P50 and the N95 components
were affected rather similarly by glaucoma in pERGs. In this
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study, pERG was performed to evaluate the damage induced by
elevated IOP to RGCs in the AEIOP dogs. pERGP50-N95
amplitude and P50op/P50ctrl ratio were obtained following
ISCEV standard.32
3 Results and Discussion
3.1 Spectroscopic Difference Between the RGCs of
AEIOP, CON, and Healthy Beagles
The optical images of the retinal tissue sections of AEIOP bea-
gle, CON beagle, and healthy beagle are shown in Fig. 1. The
layers of RGCs were identified under the microscope, as shown
in the figures. To compare the biochemical changes represented
by the Raman spectroscopic signatures, we measured Raman
spectra from 133 RGCs from five healthy beagles with normal
vision, 114 RGCs from seven AEIOP beagles, and 160 RGCs
from six CON beagles. The difference spectra were acquired by
subtracting the average spectrum of control (healthy beagle)
from the diseased (AEIOP or CON) average spectra (Fig. 2).
The wave number and intensity changes in the Raman bands
are indicative of changes in the secondary structure and varia-
tions of intracellular proteins as well as local cellular
environments. Looking at the actual and difference spectral
graphs between AEIOP, CON, and normal beagles (Fig. 2),
we noted hikes corresponding to the Amide III (1252 cm−1)
and Amide I (1656 cm−1) peaks in both conditions. The
differences in these regions between AEIOP, CON, and normal
dogs are all over three times of the standard deviations (std)
within each group (i.e., stds of pooled AEIOP spectra, CON
spectra, and normal spectra); hence, they represent the true spec-
tral changes between groups. While the total protein concentra-
tion indicated by the Amide III peak31 seems to be increased in
both conditions, suggesting an elevated protein synthesis in the
RGCs, there are significant differences in the Raman bands of
various amino acids at 800 to 1200 cm−1 in AEIOP/CON RGCs
compared to healthy RGCs. This suggests that either different
genes are being expressed leading to a different protein compo-
sition in each of the two conditions or gene expression levels are
different in each of the two conditions. Both represent changes
at a molecular level inside the RGCs. The Amide I peak, on the
other hand, may be caused by different concentrations of cho-
lesterol, ceramide, and unsaturated fatty acids which have cis
C═C Raman bands at 1650 cm−1. Also, the difference spectra
reveal that, in general, the changes in AEIOP RGCs are more
Fig. 1 Optic images of retinal tissue sections from a AEIOP beagle (a), a CON beagle (b), and a healthy beagle (c) on gold-coated slides (RGC-retinal
ganglion cell layer).
Fig. 2 (a), Average spectrum of RGCs from AEIOP beagles and healthy beagles, and the difference spectrum between them. (b), Average spectrum of
RGCs from CON beagles and healthy beagles, and the difference spectrum between them. Difference spectra were acquired by subtracting the average
spectrum of control (healthy) from the diseased (AEIOP or CON) dogs.
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significant than those of CON RGCs. This is consistent with the
fact that AEIOP has a more direct and probably more general-
ized impact on the RGCs than CONs.
3.2 Spectroscopic Differences Between AEIOP/CON
Beagles and Advanced Glaucoma in Basset
Hounds (BaGlau)
Another interesting comparison is between AEIOP, which
mimics acute/early-stage glaucoma, CON, which is a different
pathological process although sharing some clinical findings
with glaucoma, and BaGlau, which probably resembles later-
stage glaucoma in our scenario. The late-stage glaucoma spectra
were acquired from diseased/control basset hounds reported pre-
viously.2 Although the different breeds may introduce additional
variations to the spectral data, it has been shown in our previous
work that the diseased/healthy conditions are still the determin-
ing factor that dictates the spectral signatures.2
In Fig. 3, we have shown the difference spectra of AEIOP,
CON, and late-stage glaucoma (BaGlau). It is clear that the
spectroscopic changes in the RGCs associated with late-stage
glaucoma are more significant than those of the AEIOP/CON
RGCs (the intensity changes associated with the disease condi-
tions are three to four times higher in late-stage glaucoma com-
paring to those of AEIOP/CON). At a later stage of disease,
most RGCs are dead and the remaining RGCs are biochemically
different from healthy living RGCs, which may explain the more
significant spectroscopic changes. Interestingly, no change is
observed for the Amide III peak (1225 cm−1) in late-stage glau-
coma RGCs, suggesting no significant change in total protein
concentration. This suggests that at an early stage of the disease,
the RGCs behave differently in terms of protein synthesis. As
we know, the spectra reflect the biochemical composition of the
cellular milieu at the time of the test. The composition of the
milieu depends on the balance between the production and
clearance of the “apoptotic” proteins and other molecules. The
qualitative differences between the spectra of AEIOP/CON and
“late” glaucoma may suggest that in late-stage glaucoma, there
are more significant changes in the protein synthesis pattern, and
the cumulative accumulation of apoptotic proteins and other
molecules in the retina might be the reason for the observed
spectroscopic differences. The summation of these changes may
potentially be used as spectroscopic markers for the in vivo diag-
nosis of glaucoma.
Another interesting observation is the overlap between the
AEIOP spectral markers and those of late-stage glaucoma in
the amino acid fingerprinting regions (700 to 1200 cm−1)
and the lack of such an overlap with the CON spectral markers.
Since AEIOP shares many pathophysiologic features of acute
glaucoma, it is reasonable to assume that spectral markers for
AEIOP may be good for early-stage glaucoma and function
as indicators of risk and susceptibility to the disease.
3.3 Discriminant Classification Using SVM
SVM using Raman spectroscopic binary barcodes was utilized
to generate discriminant classification models to classify a mea-
sured spectrum from a retinal tissue sample into groups of two
categories (AEIOP and healthy, CON and healthy, AEIOP and
CON). One hundred and thirty-three spectra measured from the
control group (five healthy beagles), 114 spectra measured from
the seven AEIOP beagles, and 160 spectra measured from six
CON beagles were used for the discriminant analysis. To con-
struct the discriminant model, the spectra from each category
were randomly assigned into 10 blocks, and 8 blocks were ran-
domly chosen to train the SVM model (the detail of the SVM
model was reported elsewhere),2 whereas the remaining two
blocks were used as validation testing sets. This training-valida-
tion cycle was repeated 10 times; each time new blocks were
constructed through random assignment. The average classifica-
tion accuracy was subsequently calculated.
Table 1 shows the classification accuracy for AEIOP/control
and CON/control with different numbers of PCs being used in
the discriminant models. At 20 PCs, with 87% of the total vari-
ance accounted for, the classification accuracies for both AEIOP
and CON reached their optimal values (81.2% and 73.3%,
respectively). The classification accuracies for the AEIOP sam-
ples are consistently better than those for the CON samples, sug-
gesting that the Raman spectral measurements of the RGCs
provided a better characterization of the AEIOP physiological
Fig. 3 Comparison between spectroscopic markers for AEIOP, CON, and late-stage close-angle glaucoma. (a), AEIOP markers versus glaucoma mark-
ers. (b), CON markers versus glaucoma markers.
Table 1 Classification accuracy (%) with different PCs used in the dis-
criminant modeling.
No. of PCs
(% of variance)
40 (92%) 20 (87%) 10 (70%)
AEIOP versus normal AEIOP 74.4 81.2 78.7
Normal 89.5 85.9 60.2
CON versus normal CON 71.6 73.3 65.5
Normal 69.7 66.4 61.6
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conditions than those of CON cases. To better detect changes
associated with CON, different cell types, or a combination of
cell types (other than RGCs) in the retinal tissue may need to be
characterized.
It is well known that classification models tend to yield high
accuracy when the training data and the validation data are
acquired from the same sources. For the spectroscopic screening
to become a viable clinical tool, it needs to classify independent
samples (not in the training pool) with high accuracy. In this
study, we investigated the classification testing with indepen-
dent validation. The average classification accuracy was then
calculated to evaluate the performance of the classification mod-
els (Fig. 4). As expected, the results confirm that an independent
validation dataset does lead to a reduction in prediction accu-
racy. When independent samples (i.e., dogs) are used for the
validation tests, individual differences between the validating
samples and the samples in the training pool that are not due
to diseases would contribute to the discriminant calculation
and result in a less accurate prediction. For AEIOP, the classi-
fication accuracy went from 82.1% to 72.6%, and for CON, it
went from 73.3% to 63.4%. Since in clinical settings, a new
patient will certainly be an “independent” sample that is not cur-
rently included in the training pool from which the discriminant
model is developed, it is more relevant from a potential appli-
cation standpoint that the independent validation should be
conducted.
Another observation is that the prediction accuracies for
AEIOP and CON are both lower than that for the late-stage glau-
coma cases (for late-stage glaucoma, an average accuracy of
97.6% was reported),2 without taking into account the effect
of independent validation. RGCs from retinal tissues of late-
stage glaucoma dogs are expected to differ more significantly
from those of healthy dogs. It was further confirmed by calcu-
lating the Euclidean distances for Raman spectra from RGCs
between group CON and group control, group AEIOP and
group control, group late-stage glaucomatous BaGlau and
group control in the multidimensional PC space. Longer
distance suggests greater separation between the groups. As
shown in Fig. 5, the distance between group late-stage glaucom-
atous and control is the highest, suggesting that most of the
significant differences were observed between the late-stage
glaucomatous group and the control group. It also shows that
the distance between the AEIOP group and the control group
is larger than that between the CON group and the control
group, which is consistent with the higher classification accu-
racy for AEIOP samples versus CON samples (82.1% versus
73.3%, respectively). The average independent prediction accu-
racy for AEIOP (72.6%) is a good indicator of the potential pre-
diction accuracy for early-stage glaucoma, which is currently
not effectively being diagnosed. In addition, this observation
also suggests that AEIOP spectra exhibit more similarity to
those of glaucomatous tissues, indicating that AEIOP is a
good model to simulate early-stage glaucoma.
3.4 Limitations and Future Directions
An interesting observation is the apparent negative correlation
between the Raman separation distance of diseased and control
groups and the electrophysiological characteristics of the RGCs
acquired by pattern electroretinography (pERGP). The separa-
tion distances between seven AEIOP dogs and the control group
(used as Raman predictive score) were calculated. This distance
measures the statistical separation between the control group
and the AEIOP dogs. However, as shown in Table 2 and
Fig. 6, the scores correlate strongly with the pERGP data in
a negative fashion. Higher pERG amplitude or ratio suggests
healthier RGCs; hence one would expect a shorter separation
between the diseased dog and the control group. However, as
shown in Table 2 and Fig. 6, an almost opposite trend is
observed. Higher pERG readings are consistent with higher sep-
aration distances, with strong correlation indicated by the high
R2 values. Dog #2 has the highest pERG readings, and the larg-
est Raman separation distance in multidimensional PC space as
well. Moreover, a strong linear correlation could be established
between the Raman separation distances and the pERG ratio
between diseased and control dogs, but the pERG amplitude
at P50 to N95 seems to correlate with the Raman separation dis-
tance in a logarithmic manner. More study is needed to explain
this controversial result. Raman spectra measure the overall
chemical compositional characteristics of the RGCs. The PC
scores for different dogs with various disease conditions may
vary in their contribution to the overall variance. The Raman
Fig. 4 Average classification accuracies for RGCs from SVM discrimi-
nant model to differentiate healthy tissues from AEIOP tissues, CON tis-
sues, and late-stage glaucomatous tissues; validated through cross-
validation dataset (training and validation data from same sample pool),
and independent validation dataset (training and validation data from
same sample pool).
Fig. 5 Distance between groups in high-dimensional space. The
Euclidean distances for Raman spectra from RGCs between group
CON and group control, group AEIOP and group control, group late-
stage glaucomatous BaGlau and group control were calculated in 20-
dimensional space (one principal component means one dimension).
The distances were recalibrated by being divided by the distance
between group BaGlau and group control.
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separation distance in PC space, therefore, may not be a direct
indicator to determine the loss of function in RGCs measured by
pERGP. Further characterization of the chemical compositional
changes in RGCs associated with the change in pERGP readings
is needed for direct identification of Raman spectral peaks that
are affected and vice versa. The pERGP measurements are con-
ducted with living tissues, whereas the Raman spectra were
measured from fixed tissue samples, which may also complicate
the correlations between the pERG readings and the Raman sep-
aration distances. Nonetheless, the strong correlation between
the pERG readings and the Raman separation distances still sug-
gested that Raman spectra of diseased retinal tissues do capture
important signatures that are correlated to the onset and progres-
sion of glaucoma-like disease such as AEIOP.
In this study, with the maximum laser exposure time at 99 s,
the threshold limit value (TLV), which determines the maximum
permissible energy exposure to the retina in an in vivo measure-
ment, is 0.82 mW∕cm2. Our power density on sample was
140 mW∕cm2, significantly higher than the TLV. To utilize
Raman spectroscopy for in vivo imaging, the laser power density
on the retina has to be greatly reduced without sacrificing
the spectral quality. A possible solution would be to utilize
pulse laser with extreme short time-resolved detection (e.g.,
picoseconds to nanoseconds). With such short detection time
(i.e., laser exposure time), background fluorescence is elimi-
nated (shorter than the fluorescence lifetime so that fluorescence
is not developed), and the signal-to-noise ratio of the Raman
spectral measurement can be significantly improved, and
much weaker Raman signals will become detectable.32,33
Extremely short detection time also allows a much higher
laser power to be applied without increasing the overall laser
energy that the retina is exposed to.
Another limitation of our study is the fact that we are looking
at an acute and a substantial loss of retinal tissue, particularly in
the AEIOP animals. This is most likely resulting in more severe
damage and dysfunctional RGCs in the retinal tissues than in the
case of early-stage glaucoma. In a more typical clinical scenario
in which a Raman system is hoped to help, open-angle glaucoma
is a more chronic disease with a much smaller number of RGCs
being lost at any particular time, leading to a less differentiable
Raman spectral signal that needs to be distinguished from that of
normal tissues.
4 Conclusion
In this study, we explore the potential of using Raman spectros-
copy for early detection and characterization of glaucoma-
like pathological anomalies. Spectroscopic markers related to
changes in intracellular protein compositions associated with
glaucoma-like anomalies of RGCs were identified. Classifica-
tion accuracy (72.6%) was achieved to identify AEIOP, a close
mimic of early-stage/acute glaucomatous damage, from inde-
pendent canine retinal tissues. Potentially, Raman spectroscopy
in combination with time-gated pulsed laser excitation can be
utilized for in vivo Raman imaging of retina and provide
early detection and diagnosis for glaucoma.
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Table 2 Pattern electroretinography parameters and calculated Euclidean distance between individual AEIOP beagles to control beagles in 20 PC
space.
AEIOP1 AEIOP2 AEIOP3 AEIOP4 AEIOP5 AEIOP6 AEIOP7
pERGP50-N95 2.81 12.4 1.07 2.03 2.51 2.36 0.52
P50op/P50 ctrl (%) 46 89 15.4 44.6 60.19 50.2 15.24
Distance 24.405 50.7 8.235 23.315 31.35 26.28 7.88
Fig. 6 Correlations between the pERG data and the Raman separation
distance predictor for AEIOP dogs. (a), Correlation between pERG P50-
N95 amplitude and Raman separation distance. (b), Correlation
between pERG P50OP/P50 control ratio and Raman separation
distance.
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